Loading clinical trials...
Loading clinical trials...
The present clinical trial, EXPRED-II, is the continuation of EXPRED-I (NCT04489043). Objective: to evaluate the feasibility of exercise in the reversibility of prediabetes after transplantation, as ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of La Laguna
Collaborators
NCT07415421 · Hyperparathyroidism, Kidney Transplantation Recipients
NCT07491653 · Prediabetes
NCT07525622 · Prediabetes
NCT05753930 · Kidney Transplantation in Highly Sensitized Patients
NCT04634591 · Obesity, Diabetes Mellitus, and more
University of La Laguna
San Cristóbal de La Laguna, Santa Cruz de Tenerife
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions